CAS.NO: 844439-96-9

Insulin Degludec, diabetes API, is an ultra-long-acting insulin analogue. Previous studies have shown that it has an ultra-long-term hypoglycemic effect and can reduce the risk of hypoglycemia. 

 

INsulinDEgludecINjection Specifications

Product Name	Insulin Degludec
Packing Specification	10g/100g/500g
Appearances	White or off-white powder
Activity: NLT 10Unit/mg	NLT 10Unit/mg
Content: 95.0%~105.0%	95.0%~105.0%
Bacterial Endotoxin	Less than 10 EU/mg
Residual HCP	NMT 10ng/mg
Residual Exogenous DNA	NMT 10ng/dose
Macromolecular Potein	NMT 0.4%
HPLC Purity	99.0%
Storage Conditions	-15℃ below, protected from light, sealed

Insulin Degludec Recommended Method

Insulin Degludec easy dissolved in acidic (pH<2.5), neutral and alkaline conditions, and can be dissolved and clarified above pH7.0.

 

Insulin Degludec Transport and Storage Stability

Transportation stability: It is transported in an ice pack to keep it active.

Storage stability: the product can be stored for at least 24 months at -15°C below.

 

Notice and Disclaimer

Pollution should be avoided during operation.

the product should not be used for diagnosis or treatment of animals or humans.

 

Now the price of Is reasonable, if you have needs, please contact us.

 

If you want to know more details ofInsulin degludec uses andInsulin degludec duration of action, please visit our website.

 

as one of the leading biopharmaceutical manufacturing companies, Is committed to offering Products through development and innovation.